Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

被引：0
|
作者：
Liezl Channing
Edina Sinanovic
机构：
[1] University of Cape Town,Health Economics Unit, School of Public Health and Family Medicine, Faculty of Health Sciences
来源：
Cost Effectiveness and Resource Allocation | / 12卷
关键词：
Cost-effectiveness analysis; New TB vaccine; Markov modelling; Childhood TB; South Africa; Tuberculosis; BCG vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa
    Dugdale, Caitlin M.
    Phillips, Tamsin K.
    Myer, Landon
    Hyle, Emily P.
    Brittain, Kirsty
    Freedberg, Kenneth A.
    Cunnama, Lucy
    Walensky, Rochelle P.
    Zerbe, Allison
    Weinstein, Milton C.
    Abrams, Elaine J.
    Ciaranello, Andrea L.
    PLOS ONE, 2019, 14 (11):
  • [42] Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study
    Reddy, Krishna P.
    Gupta-Wright, Ankur
    Fielding, Katherine L.
    Costantini, Sydney
    Zheng, Amy
    Corbett, Elizabeth L.
    Yu, Liyang
    Van Oosterhout, Joep J.
    Resch, Stephen C.
    Wilson, Douglas P.
    Horsburgh, C. Robert, Jr.
    Wood, Robin
    Alufandika-Moyo, Melanie
    Peters, Jurgens A.
    Berg, Kenneth A. Freed
    Lawn, Stephen D.
    Walensky, Rochelle P.
    LANCET GLOBAL HEALTH, 2019, 7 (02): : E200 - E208
  • [43] Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    Hornberger, John
    Robertus, Katherine
    ANNALS OF INTERNAL MEDICINE, 2006, 145 (05) : 317 - 325
  • [44] Modelling the cost-effectiveness of wallaby control in New Zealand
    Choquenot, D
    Warburton, B
    WILDLIFE RESEARCH, 2006, 33 (02) : 77 - 83
  • [45] Modelling the cost-effectiveness of wallaby control in New Zealand
    Choquenot, D
    Warburton, B
    NINETEENTH VERTEBRATE PEST CONFERENCE, PROCEEDINGS, 2000, : 169 - 174
  • [46] Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis
    Basu, Sanjay
    Wagner, Ryan G.
    Sewpaul, Ronel
    Reddy, Priscilla
    Davies, Justine
    LANCET GLOBAL HEALTH, 2019, 7 (02): : E270 - E280
  • [47] Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
    Vassall, Anna
    Siapka, Mariana
    Foster, Nicola
    Cunnama, Lucy
    Ramma, Lebogang
    Fielding, Katherine
    McCarthy, Kerrigan
    Churchyard, Gavin
    Grant, Alison
    Sinanovic, Edina
    LANCET GLOBAL HEALTH, 2017, 5 (07): : E710 - E719
  • [48] DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S141 - S141
  • [49] The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique
    Griffiths, UK
    Hutton, G
    Pascoal, ED
    HEALTH POLICY AND PLANNING, 2005, 20 (01) : 50 - 59
  • [50] Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
    Nsengiyumva, Ntwali Placide
    Campbell, Jonathon R.
    Oxlade, Olivia
    Vesga, Juan F.
    Lienhardt, Christian
    Trajman, Anete
    Falzon, Dennis
    Den Boon, Saskia
    Arinaminpathy, Nimalan
    Schwartzman, Kevin
    PLOS MEDICINE, 2022, 19 (06)
12345